TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02667405

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hot Pack
Description: Patients have a hot pack and 2 layers of towel wrapped around the wrist and forearm for 15 minutes

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Whirlpool
Description: Patients immerse their arm, from elbow to hand, in a whirlpool bath of 104 degrees Fahrenheit for 15 minutes
Study: NCT02523469

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ALT-803

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Study: NCT01861379

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ghost Ileostomy
Description: At the end of Laparoscopic Anterior Rectal Resection, once the colorectal anastomosis was performed, the terminal ileum was identified and a window in the mesentery was created to pass a rubber tube (we usually use an urinary catheter) around the intestinal loop. The tube was subsequently exteriorized trough the trocar incision in the right flank.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Ghost Ileostomy
Description: At the end of Laparoscopic Anterior Rectal Resection, once the colorectal anastomosis was performed, the terminal ileum was identified and a window in the mesentery was created to pass a rubber tube (we usually use an urinary catheter) around the intestinal loop. The tube was subsequently exteriorized trough the trocar incision in the right flank.
Study: NCT03860415

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vivomixx
Description: Two months of 2 sachets vivomixx each morning and 2 sachets each night. Each sachet of viviomixx contains 450 billion live bacteria.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two months of 2 sachets placebo each morning and 2 sachets each night. Each sachet of placebo contains 450 billion live bacteria.
Study: NCT00828438

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10mg
Study: NCT01211431

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference
Description: Intrathécale morphine is used for post-cesarean pain control

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental
Description: A solution including both ropivacain and diclofenac continuously delivered to the wound is used for post-cesarean pain control
Study: NCT00373438

Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Fetoscopic tracheal balloon occlusion
Description: Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fetoscopic tracheal balloon occlusion
Description: Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes
Study: NCT00391183

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biliary stenting
Description: ERCP and stenting
Study: NCT04306991

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auscultation using an electronic stethoscope (EKO CORE 4)
Description: * Auscultation using an electronic stethoscope (EKO CORE 4). Record of at least 3 cardiac cycles.~* Measurement of cardiac output using echocardiography.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auscultation using an electronic stethoscope (EKO CORE 4)
Description: * Auscultation using an electronic stethoscope (EKO CORE 4). Record of at least 3 cardiac cycles.~* Measurement of cardiac output using echocardiography.
Study: NCT03616223

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FX-322
Description: Intratympanic injection of FX-322 consists of laduviglusib and sodium valproate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FX-322
Description: Intratympanic injection of FX-322 consists of laduviglusib and sodium valproate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intratympanic injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intratympanic injection
Study: NCT02217774

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MGUIDE MORE
Description: MGUIDE MORE System (MGS), consisting of MGUIDE MORE software, MGUIDE MORE surgical kit and MGUIDE MORE template, will be used for planning, drilling and inserting dental implants.
Study: NCT00942071

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-NP+M1
Description: 1. Intradermal injection at 5 x 10\^7 pfu at day 0

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-NP+M1
Description: 2.Intramuscular injection at 5 x 10\^7 pfu/ml at day 0. Intramuscular injection at 2.5 x 10\^8 pfu/ml at day 0

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-NP+M1
Description: 3.Intramuscular injection at 1.5 x 10\^8 pfu/ml at day 0
Study: NCT05060809

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oral vitamin k1 (phylloquinone)
Description: The enrolled patients received 5 mg of oral vitamin K1 (phylloquinone) three times /week for 6 months at the end of HD session to ensure compliance. We measured the serum dephosphorylated- uncarboxylated matrix Gla protein (dp-ucMGP) before and 6 months after vitamin K1 supplementation. In addition, plain lateral abdominal x-ray was conducted prior to and after 6 months of vitamin K supplementation to assess lumbar aorta calcification. The extent of aortic calcification score (AAC) was assessed by a semi-quantitative grading system developed by Kauppila.
Study: NCT01917877

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab 7mg/kg iv on day1 and 21, followed by Dexamethasone 10mg iv d 1-10, then 5mg iv d11-15, 2.5mg iv d16-20

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone 10mg iv d 1-10, then 5mg iv d11-15, 2.5mg iv d16-20
Study: NCT04986878

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: single-shot adductor canal block
Description: An ultrasound machine (Philips; Model: OTD020, AcBel Polytech Inc., Taiwan) with a 5-10 MHz linear probe was used to perform the adductor canal block immediately postoperatively.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: single-shot adductor canal block
Description: An ultrasound machine (Philips; Model: OTD020, AcBel Polytech Inc., Taiwan) with a 5-10 MHz linear probe was used to perform the adductor canal block immediately postoperatively.
Study: NCT03962686

Intervention type: DRUG
Intervention: statin Oral Tablet plus PCSK9i
Description: Patients in the third study cohort will receive for statin oral therapy plus 140 mg twice a month PCSK9i therapy via subcutaneous injection before to practice surgical intervention for carotid artery obstruction.
Study: NCT01013467

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CoCo colour coded blood pressure control
Description: The patients in the intervention group will receive a colour-coded blood pressure record booklet. The corresponding colour coded areas are divided into three areas of green, yellow and red following a traffic light system. The green area covers blood pressure readings up to a maximum of 140/90 mmHg, the yellow area includes systolic readings over 140 to 180 mm Hg and diastolic readings over 90 to 110 mmHg. The red area covers systolic readings over 180 mmHg and diastolic readings over 110 mmHg.
Study: NCT03020615

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Description: Given orally once daily.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyurea
Description: Given orally once daily.
Study: NCT01684241

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RBL001/RBL002
Description: Each participant will receive 8 repeated intranodal administrations of RBL001 and RBL002 during a time frame of 43 to 51 days.
Study: NCT01086241

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 2D Mammogram
Description: Those patients randomized to the mammogram arm will receive a regular 2D mammogram. Compression lasts several seconds in order to obtain 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tomosynthesis
Description: Those patients randomized to the tomosynthesis arm will receive a combination of 3D and 2D screening mammogram. The additional tomosynthesis data is obtained immediately after acquisition of the 2D study, with the patient and breast remaining in the same position and compression. Compression lasts about 7 seconds longer for each of the 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.
Study: NCT00410488

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vincristine
Description: 2 mg IV by rapid administration on day 0 (for patients with small cell histology).~For patients with certain types of sarcoma, vincristine will be given through the catheter by rapid infusion on Day 0 only.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: IV piggyback (IVPB) daily for 5 days (12 mg on day 0, and 8 mg on days 1-4) 30 minutes prior to chemotherapy.
Study: NCT05267691

Intervention type: PROCEDURE
Intervention: Excision
Description: Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains

Intervention type: PROCEDURE
Intervention: Excision
Description: Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains
Study: NCT02467205

Intervention type: OTHER
Group type: OTHER
Intervention: pedometer supported walking and education
Description: A Physical activity; pedometer will be given to each person in the intervention group at the first education session. Participants will be encouraged to use the pedometer for a 6 month period.~The strength exercises will be performed at home. Education will incorporate the behavioural change techniques (BCTs) known to be effective in increasing physical activity (Goal setting,Self-monitoring of behaviour,Feedback on outcomes of behaviour,Problem solving,Relapse Prevention (RP) and social support).
Study: NCT02557087

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyoscine
Study: NCT03049384

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Exercise
Description: The traditional exercise group will undertake a supervised exercise intervention involving aerobic exercise and light resistance training, in line with published guidelines for exercise in cancer survivors.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored Exercise
Description: The tailored training group will be prescribed an individualized exercise intervention designed specifically to counteract deficits (e.g. neuromuscular) of difficulties (e.g. sleep disturbance) identified during pre-intervention testing.
Study: NCT02296177

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Peace of Mind Program
Description: The Peace of Mind Program (PMP) is a telephone counseling program based on the Transtheoretical Model of Change, with messages matched to readiness (assessed with a stage of change question)and barriers identified by women who are non-adherent to mammography. The program telephone protocol guides counselors to assess a woman's readiness to be screened and counsel her through barriers to increase appointment keeping.
Study: NCT02865005

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapsone 5.0% Gel (SEEGPharm)
Description: Topical Gel

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical Gel
Study: NCT02557087

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pethidine
Study: NCT02185391

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Audience Response System
Description: patients use during oral presentations an audience response system

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone interview
Description: patients receive motivational telephone interviews after their residence in rehabilitation clinics
Study: NCT02865005

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapsone 5.0% Gel (Allergan)
Description: Topical Gel
Study: NCT02829762

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Program of geriatric and Social intervention associated techniques of Domotic and Remote assistance
Description: Implementation of social aids, a monthly social monitoring and home improvement with domotic techniques and remote assistance
Study: NCT00410488

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: IV piggyback (IVPB) daily for 5 days (12 mg on day 0, and 8 mg on days 1-4) 30 minutes prior to chemotherapy.
Study: NCT04144972

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Medtronic Summit RC+S or Percept RC
Description: The investigators will perform DBS versus sham (randomized) to evaluate efficacy of stimulation for analgesia. Closed-loop DBS will be compared to open-loop DBS in a patient blinded, randomized fashion after initial, efficacy evaluation.
Study: NCT00804271

Intervention type: DRUG
Group type: OTHER
Intervention: memantine
Description: memantine tablets, OD, 12 weeks
Study: NCT04144972

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Medtronic Summit RC+S or Percept RC
Description: The investigators will perform DBS versus sham (randomized) to evaluate efficacy of stimulation for analgesia. Closed-loop DBS will be compared to open-loop DBS in a patient blinded, randomized fashion after initial, efficacy evaluation.
Study: NCT02827539

Intervention type: DEVICE
Group type: OTHER
Intervention: LessRay
Description: A software device has been developed that combines the benefits of reduced radiation associated with low-dose and/or pulse settings while preserving and possibly offering enhanced resolution. LessRay is a software device that is viewed on a separate monitor next to the fluro screen of the C-arm.

Intervention type: DEVICE
Group type: OTHER
Intervention: Standard Fluoroscopy
Description: For control arm, patients will receive the standard fluoroscopy for imaging.
Study: NCT01199614

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: open-label PTH(1-84)
Description: open label PTH(1-84) at either 25mcg every other day, 25mcg every day, 50mcg daily, 75mcg daily, or 100mcg daily
Study: NCT01021384

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Problem Solving Education
Description: Problem Solving Education (PSE) is an evidenced-based empowerment strategy, targeted to mothers of young children to promote family well-being by decreasing the burden of maternal depressive symptoms and maternal parenting stress and improving social functioning.
Study: NCT05622903

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cash Benefit
Description: Spending from the cards was not restricted to food but could be spent on anything and anywhere Visa was accepted. The debit cards were credited with the first payment on November 18th, 2020 and the second payment on December 18th, 2020. The program continued with monthly credits through August 2021.
Study: NCT04475861

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-arginine supplements and nutritional supports
Description: The enrolled subjects will then be randomized into two groups. The subjects will receive either L-arginine (the study group) or another amino acid supplement (the control group), with 60 patients in each group. All the food intake of the subjects during the 4 weeks of the study will be recorded and supervised by responsible dietitians.
Study: NCT01054898

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: advocacy intervention
Description: A 12-week telephone social support and empowerment intervention consisting of empowerment training, scheduled weekly telephone calls, and 24-hour access to a hotline for abused women

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual community services
Description: standard care for abused women in the community
Study: NCT01561664

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle and fat biopsy
Description: muscle and fat biopsy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle and fat biopsy
Description: muscle and fat biopsy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: muscle and fat biopsy
Description: muscle and fat biopsy
Study: NCT03013465

Intervention type: OTHER
Group type: OTHER
Intervention: Control Diet
Description: Participants will receive a controlled diet with 0 g/d of broccoli. Meals will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Base Diet with Broccoli
Description: Participants will receive a controlled diet with 100 g of broccoli at both breakfast and dinner daily. Meals will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Study: NCT04240587

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TrueTear™ intranasal neurostimulator (ITN)
Description: The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN active arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN sham arm will receive tips without the current.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TrueTear™ intranasal neurostimulator (ITN)
Description: The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN active arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN sham arm will receive tips without the current.
Study: NCT04059744

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fun-Knee
Description: Portable and low cost sensors are used in the Smart Knee Sleeve. The sensor system is composed of two inclinometers and one Bluetooth transmitter.~Fun Knee™ contains total knee replacement exercises that are gamified and supported on mobile device running on Android or iOS platforms. The mobile apps is able to capture the angle a and position data from the two inclinometers on smart knee sleeve.The free-sized knee sleeve prototypes are purchased and assembled by our collaborating vendor.
Study: NCT03674021

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest Pain Choice visual aid
Description: The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain. The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.
Study: NCT01480739

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg (50 mg x 2) AZD5069
Description: Twice daily for 7 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg Placebo
Description: Twice daily for 7 days
Study: NCT03492593

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lycopene
Description: A tomato oleoresin containing lycopene

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: beta-carotene
Description: 13C beta-carotene

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: emulsified liquid meal alone
Study: NCT02016248

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Body Radiotherapy as Monotherapy
Description: The prescribed planned tumor volume (PTV) dose of 36.25 Gy shall be given in 5 fractions using CyberKnife Hypofractionated Stereotactic Ablative Body Radiation Therapy. PTV will be defined per parameters outlined in the protocol and will at minimum include the entire prostate gland.
Study: NCT05622903

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Cash Benefit
Description: No monthly cash benefit.
Study: NCT02644434

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Strategy
Description: Jailed wire technique: Both MV and SB are wired. The MV is stented with wire protection in SB. The SB is not further treated unless there is threatened SB closure, severe ostial pinching of SB (\>90%), TIMI flow grade decrease in SB, or SB dissection greater than type A. If one of these criteria exists, the SB would be rewired and a kissing balloon inflation is undertaken.~Provisional two-stent strategy: Lesion preparation and MV stenting are the same as the jailed wire technique. Provisional T stenting of the SB could be undertaken if one of the following criteria exists after SB rewiring and a kissing balloon inflation is undertaken: threatened SB closure, severe ostial pinching of SB (\>90%), TIMI flow grade decrease in SB, or SB dissection greater than type A.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intentional strategy
Description: Jailed balloon technique: The technique has been detailed in previous studies. A monorail balloon that is angiographically sized to approximate the Side Branch (SB) vessel diameter is advanced into the SB. If there is TIMI flow grade decrease in the SB after MV stenting, the SB balloon is inflated to simulate attempt to reopen the SB. The procedure would be completed with the standard kissing balloon technique no matter there is SB compromise or not.~Elective two-stent strategy: Patients in this subgroup would undergo crush procedure or any other elective two-stent strategy which stenting SB before MV stenting.